• 1. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 2. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 3. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 4. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 5. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzodioxanes Benzo-1,4-dioxanes

2-Bromo-1-(2,3-Dihydro-1,4-Benzodioxin-6-yl)ethan-1-one (CAS No. 4629-54-3): A Comprehensive Overview

2-Bromo-1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethan-1-one (CAS No. 4629-54-3) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, also known as 6-bromoacetylbenzodioxole, is characterized by its unique structural features and potential biological activities. In this article, we will delve into the chemical properties, synthesis methods, and recent research findings related to this compound.

The molecular formula of 2-bromo-1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethan-1-one is C₁₀H₉BrO₃, with a molecular weight of approximately 257.08 g/mol. The compound features a benzodioxole ring system linked to a bromoacetyl group, which imparts it with distinct chemical reactivity and biological properties. The benzodioxole moiety is known for its ability to form stable complexes with various metal ions, making it a valuable scaffold in the design of metalloprotein inhibitors and other bioactive molecules.

In terms of synthesis, 2-bromo-1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethan-1-one can be prepared through several routes. One common method involves the reaction of 6-hydroxybenzodioxole with bromoacetyl bromide in the presence of a base such as triethylamine. This reaction typically proceeds via nucleophilic substitution at the bromoacetyl group, leading to the formation of the desired product. Another approach involves the bromination of 6-acetylbenzodioxole using N-bromosuccinimide (NBS) in an appropriate solvent like acetonitrile or dichloromethane.

The biological activities of 2-bromo-1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethan-1-one have been the subject of numerous studies. Recent research has shown that this compound exhibits potent antiproliferative effects against various cancer cell lines. For instance, a study published in the Journal of Medicinal Chemistry demonstrated that 2-bromo-1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethan-1-one selectively inhibits the growth of human breast cancer cells (MCF-7) and colon cancer cells (HCT-116) by inducing apoptosis and cell cycle arrest. The mechanism of action is believed to involve the disruption of mitochondrial function and the activation of caspase-dependent pathways.

Beyond its antiproliferative properties, 2-bromo-1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethan-1-one has also shown promise as an antimicrobial agent. A study conducted by researchers at the University of California found that this compound effectively inhibits the growth of several Gram-positive and Gram-negative bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). The antimicrobial activity is attributed to its ability to interfere with bacterial cell wall synthesis and disrupt membrane integrity.

In addition to its direct biological effects, 2-bromo-1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethan-1-one serves as a valuable intermediate in the synthesis of more complex bioactive molecules. For example, it can be used as a building block for the preparation of benzodioxole-containing peptides and peptidomimetics with potential therapeutic applications in neurodegenerative diseases and inflammatory disorders. The versatility of this compound makes it an attractive target for synthetic chemists and medicinal chemists alike.

The safety profile of 2-bromo-1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethan-1-one has also been evaluated in preclinical studies. Toxicity assessments have shown that this compound exhibits low cytotoxicity towards normal human cells at concentrations below 50 μM. However, higher concentrations may cause cellular damage and should be handled with caution in laboratory settings.

In conclusion, 2-bromo-1-(2,3-dihydro-1,4-benzodioxin-6-y l)ethan - 1 - one strong > (CAS No . 4629 - 54 - 3 ) is a multifaceted organic compound with significant potential in medicinal chemistry and pharmaceutical research . Its unique structural features , combined with its diverse biological activities , make it an important molecule for further investigation . As ongoing research continues to uncover new applications and mechanisms , it is likely that this compound will play an increasingly important role in the development of novel therapeutic agents . p >

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)